Characteristics and influencing factors of pain in amyotrophic lateral sclerosis: a focus on symptom management
- PMID: 40884702
- DOI: 10.1007/s10072-025-08444-9
Characteristics and influencing factors of pain in amyotrophic lateral sclerosis: a focus on symptom management
Abstract
Purpose: To investigate the characteristics and influencing factors of pain symptoms in ALS patients, provide references for the formulation of pain coping measures in clinical practice.
Materials and methods: The research design was a cross-sectional study.ALS patients were investigated using scales such as the Brief Pain Inventory (BPI). Binary logistic regression equation and multiple linear regression equation were used to analyze the influencing factors of whether occur pain and pain degree in ALS patients.
Results: 149 (74.1%) patients had pain symptoms, and 51 (25.4%) patients had pain as the first symptom. Patients with moderate to severe pain accounted for 60.4%. Fatigue, social support, self-efficacy, and poor sleep quality have been associated with whether occur pain in ALS patients. Personality traits, education, fatigue, social support, physical function, and self-efficacy were associated with pain levels in ALS patients.
Conclusions: Pain is an important indicator of functional decline, which can directly affect the rehabilitation outcome, reduce the quality of life of patients, and is crucial for predicting disease progression and optimizing end-of-life care, which should arouse the full attention of clinical medical personnel and scientific researchers. In the future, it is necessary to strengthen pain intervention in rehabilitation programs.
Keywords: Amyotrophic lateral sclerosis; Characteristics; Influencing factors; Pain; Rehabilitation.
© 2025. Fondazione Società Italiana di Neurologia.
Conflict of interest statement
Declarations. Ethics approval: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Hospital Ethics Review Committee of Peking University Third Hospital(IRB00006761 --M2023423). Informed consent: was obtained from all individual participants included in the study. Competing interests: The authors have no relevant financial or non-financial interests to disclose.
Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Interventions for fatigue and weight loss in adults with advanced progressive illness.Cochrane Database Syst Rev. 2012 Jan 18;1:CD008427. doi: 10.1002/14651858.CD008427.pub2. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2017 Apr 07;4:CD008427. doi: 10.1002/14651858.CD008427.pub3. PMID: 22258985 Updated.
-
WITHDRAWN: Interventions for fatigue and weight loss in adults with advanced progressive illness.Cochrane Database Syst Rev. 2017 Apr 7;4(4):CD008427. doi: 10.1002/14651858.CD008427.pub3. Cochrane Database Syst Rev. 2017. PMID: 28387447 Free PMC article.
-
Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron disease.Cochrane Database Syst Rev. 2017 Jan 10;1(1):CD011776. doi: 10.1002/14651858.CD011776.pub2. Cochrane Database Syst Rev. 2017. PMID: 28072907 Free PMC article.
-
Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease.Cochrane Database Syst Rev. 2017 Oct 6;10(10):CD004427. doi: 10.1002/14651858.CD004427.pub4. Cochrane Database Syst Rev. 2017. PMID: 28982219 Free PMC article.
References
-
- Feldman EL, Goutman SA, Petri S, Mazzini L, Savelieff MG, Shaw PJ et al (2022) Amy-otrophic lateral sclerosis. Lancet(London England) 400(10360):1363–1380. https://doi.org/10.1016/S0140-6736(22)01272-7 - DOI - PubMed
-
- Gowland A, Opie-Martin S, Scott KM, Jones AR, Mehta PR, Batts CJ et al (2019) Predicting the future of ALS: the impact of dem-ographic change and potential new treatments on the prevalence of ALS in the united Kingdo-m, 2020–2116. Amyotroph Lateral Scler; Frontotemporal Degener 20(3–4):264–274. https://doi.org/10.1080/21678421.2019.1587629 - DOI - PubMed - PMC
-
- Xu L, Chen L, Wang S, Feng J, Liu L, Liu G et al (2020) Inci-dence and prevalence of amyotrophic lateral sclerosis in urban china: a National population-ba-sed study. J Neurol Neurosurg Psychiatry 91(5):520–525. https://doi.org/10.1136/jnnp-2019-322317 - DOI - PubMed
-
- Beswick E, Forbes D, Hassan Z, Wong C, Newton J, Carson A et al (2022) A systematic review of non-motor symptom evaluation in clinical trials for amyotrophic lateral sclerosis. J Neurol 269(1):411–426. https://doi.org/10.1007/s00415-021-10651-1 - DOI - PubMed
-
- Di L, Chen H, Da Y, Wang S, Shen XM (2016) Atypical familial amyotrophic lateral sclerosis with initial symptoms of pain or tremor in a Chinese family harboring VAPB-P56S mutatio-n. J Neurol 263(2):263–268. https://doi.org/10.1007/s00415-015-7965-3 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous